- Home
- SPE vs SRZN Comparison
SPE vs SRZN Comparison
Compare SPE & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPE | SRZN |
|---|---|---|
| Founded | 1993 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.8M | 164.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SPE | SRZN |
|---|---|---|
| Price | $14.96 | $23.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 25.4K | ★ 145.3K |
| Earning Date | 01-01-0001 | 11-07-2025 |
| Dividend Yield | ★ 8.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,604,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.26 | $5.90 |
| 52 Week High | $12.59 | $24.94 |
Technical Indicators
Market Signals| Indicator | SPE | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 57.27 |
| Support Level | $14.92 | $18.74 |
| Resistance Level | $15.02 | $24.07 |
| Average True Range (ATR) | 0.14 | 1.95 |
| MACD | 0.01 | 0.19 |
| Stochastic Oscillator | 45.37 | 72.92 |
Price Performance
Historical ComparisonAbout SPE Special Opportunities Fund Inc
Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).